The new quick and simple at-home tests that could mean the end of painful gynae check-ups - and cut the time it takes to diagnose womb cancer

The new quick and simple at-home tests that could mean the end of painful gynae check-ups - and cut the time it takes to diagnose womb cancer

Two quick and simple tests that women can do themselves at home could cut the time it takes to diagnose womb cancer.Developed at the University of Manchester, the new checks detect cancer cells in urine and vaginal fluid – in trials they proved almost as reliable as the invasive and often painful procedures used currently. These include vaginal ultrasound scans, hysteroscopies (where a probe with a camera on the end is inserted into the womb) and biopsies, where a small amount of tissue is surgically removed for testing. The breakthrough could mean millions of women will in future be able to simply collect their own samples at home to send off for testing in a laboratory – rather than endure unpleasant and sometimes traumatic checks.Every year in the UK, more than 800,000 women see their GP for abnormal bleeding.Roughly 10,000 of these are diagnosed with womb cancer. Cases of the disease have increased by almost 60 per cent since the 1990s, partly due to rising rates of obesity, which increases levels of oestrogen in the body – this can cause the lining of the womb to grow too much, raising the risk of womb cancer.The disease is most common in post-menopausal women with unexplained bleeding.Many currently undergo unpleasant tests to rule out cancer – even though, in the vast majority of cases, post-menopausal bleeding is caused by natural changes of the lining of the womb which happen with age, or other benign conditions such as fibroids.‘We chose urine because samples are easy to self-collect,’ says Emma Davidson, a professor of gynaecological oncology at the University of Manchester and lead author of a study which analysed the accuracy of the test. ‘We chose urine because samples are easy to self-collect,’ says Emma Davidson, a professor of gynaecological oncology at the University of Manchester, who is the lead author of a study which analysed the accuracy of the test‘Vaginal fluid was also selected because of the anatomical proximity of the vagina to the uterus, which could provide a richer source of cancer cells shed from endometrial tumours.’The new tests are based on previous observations that womb cancer cells shed continuously into the lower genital tract.Researchers used the tests on 1,864 women with post-menopausal bleeding seen at seven hospitals in north-west England.Each woman provided a urine sample and a vaginal fluid sample, which were examined for abnormal cells.The same women then went on to have the usual clinical investigations, including vaginal ultrasounds and biopsies.A total of 115 women were diagnosed with cancer, including 99 cases of womb cancer and a smaller number of other pelvic cancers.The urine and vaginal fluid checks detected over 80 per cent of tumours. But they proved particularly good at spotting high-grade cancers – 95.8 per cent – as well as 96.4 per cent of those that had already spread beyond the uterus, a similar rate of success to existing detection methods.They were also highly accurate at spotting those who were cancer-free, reported the researchers in the journal Lancet Obstetrics, Gynaecology and Women’s Health.The findings could help reassure thousands of women who have unexplained bleeding but do not have malignant disease.Athena Lamnisos, CEO of The Eve Appeal, a leading gynaecological cancer charity, said that the new study was an important step.‘Anything that gets a woman her results more quickly and is both more comfortable and accurate is very welcome,’ she says.‘These are very promising early results, but while it was particularly good at finding the aggressive and advanced cancers, it missed a number of small, early, slow-growing cancers. So further research into these tests is needed.’She added that the test could avoid the need for other diagnostic checks in women who don’t show a high risk of cancer – allowing medics to focus on those who do.It could also save the NHS money, says Professor Davidson, by cutting spending on expensive equipment and trained personnel for women who turn out not to have cancer – ‘the estimated cost of a full diagnostic pathway is around £750 per patient, and that doesn’t take into account the fact that around 30 per cent of hysteroscopies and biopsies fail and need to be repeated,’ she adds.Scientists are also looking at other non-invasive ways to detect womb cancer.Researchers at Nottingham University Hospitals NHS Trust are developing a test that measures changes in a chemical ‘fingerprint’ of proteins, fats and other molecules in blood and urine, that signal the presence of cancer cells.Meanwhile, women in Somerset are being encouraged to bypass their GP surgery altogether and refer themselves to a specialist if they have unexplained post-menopausal bleeding.Under the new scheme, the first step is filling in an online form, or calling an adviser, to complete a brief medical history. Patients are then contacted within 24 hours and, if needs be, given an appointment for urgent investigation.The scheme has cut the waiting time to see a consultant from an average of 63 days to just five days – with cancer patients being diagnosed in just 22 days – boosting chances of survival.David Milliken, a consultant gynaecological oncologist at Somerset NHS Foundation Trust, said: ‘We are seeing a year-on-year increase in referrals to our gynaecology cancer services, particularly for post-menopausal bleeding.‘With this scheme, we can avoid unnecessary delays and get them an appointment more quickly.’

Original Source

Read the full article at Dailymail →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.